Calcium channel blockers and atherogenesis

Area of Science:

• Cardiovascular Research
• Pharmacology
• Atherosclerosis Pathogenesis

Background:

• Atherogenesis involves complex cellular and molecular events, including platelet deposition, smooth muscle cell proliferation, matrix formation, lipoprotein complexation, and calcification.
• Calcium plays a critical role in multiple stages of atherogenesis, influencing cellular events and matrix deposition.
• Altering calcium influx has shown varied effects on experimental atherosclerosis severity and progression.

Purpose of the Study:

• To investigate the role of calcium channel blockers in attenuating the development of experimental atherosclerosis.
• To evaluate the efficacy of calcium channel blockers in preventing and potentially reversing atherosclerotic lesion progression.
• To assess the impact of calcium channel blockers in models with altered lipid metabolism relevant to human atherosclerosis.

Main Methods:

• Utilized rabbit models to study the effects of calcium channel blockers (nifedipine, verapamil, diltiazem) on experimental atherosclerosis.
• Examined the impact of interventions that increase or decrease calcium deposition on atherosclerotic lesion severity.
• Investigated calcium channel blocker efficacy in rabbits with deficiencies in low-density lipoprotein receptors.

Main Results:

• Interventions increasing calcium deposition exacerbated experimental atherosclerosis, while those reducing calcium entry mitigated progression.
• Calcium channel blockers demonstrated a protective effect against the development of experimental atherosclerosis in rabbits.
• Calcium channel blockers showed limited efficacy in inducing regression of established atherosclerotic lesions.
• Protection was not observed in rabbits deficient in low-density lipoprotein receptors, suggesting a role for lipid metabolism.

Conclusions:

• Calcium channel blockers may offer a protective effect against the development of experimental atherosclerosis, primarily by modulating calcium influx.
• Their effectiveness in promoting regression of atherosclerotic plaques appears limited.
• The absence of protection in LDL receptor-deficient models highlights the interplay between calcium modulation and lipid metabolism.
• Further clinical studies are needed to determine the relevance of these findings for human cardiovascular health and antihypertensive therapy selection.